VITR logo

Vitrolife AB (publ) Stock Price

OM:VITR Community·SEK 18.0b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

VITR Share Price Performance

SEK 132.70
-75.30 (-36.20%)
SEK 230.00
Fair Value
SEK 132.70
-75.30 (-36.20%)
42.3% undervalued intrinsic discount
SEK 230.00
Fair Value
Price SEK 132.70
AnalystHighTarget SEK 230.00
AnalystConsensusTarget SEK 193.50

VITR Community Narratives

AnalystHighTarget·
Fair Value SEK 230 42.3% undervalued intrinsic discount

IVF Technology Adoption And Genetic Testing Demand Will Drive Strong Long-Term Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value SEK 193.5 31.4% undervalued intrinsic discount

Profit Margins And Revenue Outlook Will Support Recovery Trends Ahead

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
SEK 230
42.3% undervalued intrinsic discount
Revenue
7.74% p.a.
Profit Margin
21.03%
Future PE
39.44x
Price in 2028
SEK 268.66
SEK 193.5
31.4% undervalued intrinsic discount
Revenue
7.15% p.a.
Profit Margin
19.33%
Future PE
36.58x
Price in 2028
SEK 225.3

Trending Discussion

Updated Narratives

VITR logo

IVF Technology Adoption And Genetic Testing Demand Will Drive Strong Long-Term Upside

Fair Value: SEK 230 42.3% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VITR logo

VITR: Higher Long Term Revenue Outlook Will Support Further Upside

Fair Value: SEK 193.5 31.4% undervalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

0 Risks
4 Rewards

Vitrolife AB (publ) Key Details

SEK 3.5b

Revenue

SEK 1.4b

Cost of Revenue

SEK 2.1b

Gross Profit

SEK 1.6b

Other Expenses

SEK 440.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 03, 2026
3.25
58.91%
12.55%
14.1%
View Full Analysis

About VITR

Founded
1989
Employees
1100
CEO
Bronwyn Brophy O´Connor
WebsiteView website
www.vitrolife.com

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Recent VITR News & Updates

Recent updates

No updates